Did you know?

On average, Wall Street analysts predict. that Rain Oncology's share price could reach $1.33 by Sep 18, 2024. The average Rain Oncology stock price prediction forecasts a potential upside of 22.29% from the current RAIN share price of $1.09.WebRAIN Stock 12 Months Forecast. $1.33. (27.88% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Rain Therapeutics in the last 3 months. The average price target is $1.33 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 27.88% change from the last price of $1.04. Which Rain Oncology insiders have been buying company stock? The following insiders have purchased RAIN shares in the last 24 months: Aaron I Davis ($5,667,995.96), Bvf Partners L P/Il ($9,971,387.14), Franklin M Berger ($351,000.00), and Kevin C Tang ($1,179,304.12).Web

Shares of Cullinan Oncology ( CGEM 3.30%) were up as much as 24.3% this week after being as high as 24.9%, according to data provided by S&P Global Market Intelligence. The stock closed last week ...November 22, 2023. $1.07. 31,967. 1:1. $1.09. $1.09. $1.06. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits …Oct 16, 2023. NEWARK, Calif., October 16, 2023 – Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding shares of common stock of Rain for $1.25 per share in cash, plus a contingent value right (“CVR”) representing the right to receive 80% of the net ...NEWARK, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN) (Rain), a late-stage biotechnology company developing precision oncology therapeutics, today announced the ...

Fourth Quarter and Full Year 2022 Financial Results. For the three months and year ended December 31, 2022, Rain reported a net loss of $22.7 million and $75.7 million, respectively, as compared ...Fourth Quarter and Full Year 2022 Financial Results. For the three months and year ended December 31, 2022, Rain reported a net loss of $22.7 million and $75.7 million, respectively, as compared ... ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Rain oncology stock. Possible cause: Not clear rain oncology stock.

1 Jun 2021 ... Rain Therapeutics (RAIN) is a clinical-stage precision oncology company. They recently went public in 2021. Co-founder and CEO, Avanish ...NEWARK, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (“Rain”) (NasdaqGS: RAIN), (Rain), a late-stage biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today announced that it will …Web

Mar 9, 2023 · Non-cash stock-based compensation expense included in G&A expenses were approximately $0.3 million and $1.1 million for the three months and year ended December 31, 2022, respectively, as compared ... Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update. Find the latest Rain Oncology Inc. (RAIN) stock quote, history, news and other vital...

us wealth management Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing. best dental insurance in georgiahcnwf stock forecast Stock Detail•Compare Perf. •Options Chain•Save to Portfolio•Create Alert Scroll to Statements Show Previous Ratings Rain Oncology, Inc. is a clinical-stage precision … zero sugar champagne Complete Rain Oncology Inc. stock information by Barron's. View real-time RAIN stock price and news, along with industry-best analysis. Find the latest Rain Oncology Inc. (RAIN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... RAIN - Rain Oncology Inc. NasdaqGS ...Web open a demo forex trading accounttrack my dividendsvoo 10 year return Stock Quote & Chart. Historical Price Lookup. ... Rain Oncology Announces Collaborator Poster Presentation at the American Association for Cancer Research (AACR ...NEWARK, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN), (Rain), a late-stage company developing precision oncology therapeutics with its lead product candidate ...Web nasdaq appn Oct 14, 2023 · Rain Oncology Inc's stock momentum and predictability metrics also paint a bleak picture. The stock's RSI 5 Day, RSI 9 Day, and RSI 14 Day are 27.25, 30.15, and 30.19 respectively, indicating a ... best option trading websitesdow jones index listbest pharma etfs Insiders who bought Rain Oncology Inc. (NASDAQ:RAIN) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$54m as a result of the stock's 21% gain ...WebBrowse 28,070 authentic oncology stock photos, high-res images, and pictures, or explore additional cancer or oncologist stock images to find the right photo at the right size and resolution for your project. Browse Getty Images' premium collection of high-quality, authentic Oncology stock photos, royalty-free images, and pictures.